Insider · CIK 0001754154
Scott M. Giacobello
cfoofficer
Files at WHWK (Whitehawk Therapeutics, Inc.). First filing Mar 3, 2025, latest Mar 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $6,594 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | Whitehawk Therapeutics, Inc. | $6,594 2,806 shares | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +118,476 | $0.00 | $0 | 118,476 | 24 d ago |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +118,476 | $0.00 | $0 | 118,476 | 24 d ago |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +118,476 | $0.00 | $0 | 118,476 | 27 d ago |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +118,476 | $0.00 | $0 | 118,476 | 27 d ago |
| Apr 1, 2025 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +473,902 | $0.00 | $0 | 473,902 | Apr 3, 2025 |
| Apr 1, 2025 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +473,902 | $0.00 | $0 | 473,902 | Apr 3, 2025 |
| Mar 1, 2025 | WHWK Whitehawk Therapeutics, Inc. | MOption exercise Common Stock | +6,750 | - | - | 26,750 | Mar 3, 2025 |
| Mar 3, 2025 | WHWK Whitehawk Therapeutics, Inc. | SOpen-market sale Common Stock | -2,806 | $2.35 | $6,594 | 23,944 | Mar 3, 2025 |
| Mar 1, 2025 | WHWK Whitehawk Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,750 | $0.00 | $0 | 20,250 | Mar 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.